Maven Securities’s AstraZeneca AZN Stock Holding History

Maven Securities’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,600	Closed	-$216K	–	408
2023 Q4	$216K	Sell	1,600 -200	-11%	-$26K	﹤0.01%	881
2023 Q3	$244K	Buy	1,800 +100	+6%	+$13.7K	﹤0.01%	998
2023 Q2	$243K	Hold	1,700	–	–	﹤0.01%	781
2023 Q1	$236K	Buy	+1,700	New	+$229K	﹤0.01%	851
2022 Q4	–	Sell	-5,400	Closed	-$592K	–	848
2022 Q3	$592K	Buy	+5,400	New	+$685K	0.01%	732
2021 Q2	–	Sell	-2,500	Closed	-$249K	–	1055
2021 Q1	$249K	Buy	+2,500	New	+$251K	0.01%	861

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maven Securities's AZN Position: Q1 2023 in Review

Maven Securities sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 2,506 shares — an estimated $337K sold.

Maven Securities first reported a position in AZN in Q1 2019 and held it in 5 quarters. The position peaked at $3.88M in Q1 2019. 1,055 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

Maven Securities reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
Maven Securities sold 2,506 AstraZeneca shares in Q1 2023, an estimated $337K.
Maven Securities first reported a position in AstraZeneca in Q1 2019 and held it in 5 quarters.
Maven Securities's AstraZeneca position peaked at $3.88M in Q1 2019.
1,055 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Maven Securities's 13F filing for Q1 2023, filed 15 May 2023.